Executive summary Elevated blood pressure is the strongest modifiable risk factor for
cardiovascular disease worldwide. Despite extensive knowledge about ways to prevent as …

Cancer starts as a localised disease, which, if detected early, can often be treated
successfully by removal of the primary tumour. A pernicious progression is the invasion of …

Objective The development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …

Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Background: Variability of blood pressure (BP) across outpatient visits is frequently
dismissed as random fluctuation around a patient's underlying BP. Objective: To examine …

Executive summary Cardiovascular disease is a major cause of disability and premature
death throughout the world, and contributes substantially to the escalating costs of health …

METHODS This CPG was developed in accordance with the AACE Protocol for
Standardized Production of Clinical Practice Guidelines—2010 Update (

Objective Hypertension is estimated to cause 4.5% of current global disease burden and is
as prevalent in many developing countries, as in the developed world. Blood pressure …

These guidelines update previous reports by working parties of the British Hypertension
Society (BHS) in 1989, 1 19932 and 1999. 3 Updating these guidelines is appropriate …

Hypertension (HTN) and chronic kidney disease are highly prevalent diseases that tend to
occur more frequently among disadvantaged populations, in whom prenatal care also tends …